With the SI in the stratosphere and its ability in all prior trials to transfer effectiveness from in vitro and vero to human trials, I feel pretty confident CV19 will prove the same.
Brilacidin simply seems to work on all indications in which it is expected to work. Guess we are stuck with a drug that always performs and performs exceedingly well.
I realize there is always risk, but I cannot imagine why it would not work in humans since it is going against the same virus it worked on in the lab. If anything, I always worry more about safety but Brilacidin has built up a very nice track record in this regard to date.
News 
Market Data 
Discover 
